Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective.
about
Non-pharmacological measures for preventing opportunistic infection in patients with haematological malignanciesCytomegalovirus infection in immunocompetent critically ill adults: literature reviewProphylactic Measures During Induction for Acute Myeloid Leukemia.Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?Monitoring of the environment at the transplant unit-hemato-oncology clinic.Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatmentInfluenza a outbreak in an ambulatory stem cell transplant center.Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units.Prospective study of dental intervention for hematopoietic malignancyRecommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patientsPharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part IEpidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center.Updated guidelines for managing fungal diseases in hematology patients.T cell immunity and vaccines against invasive fungal diseases.Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients.HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis.Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice.Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis.Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation.Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation.Testing an innovative device against airborne Aspergillus contamination.A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.A review of late complications of allogeneic hematopoietic stem cell transplantations.Intensity and duration of neutropenia relates to the development of oral mucositis but not odontogenic infection during chemotherapy for hematological malignancy.Comparison of prophylactic use of intravenous immunoglobulin versus Pentaglobin® in pediatric patients after hematopoietic stem cell transplantation.
P2860
Q24193921-54762C12-A475-4EBB-AC99-F5AF10EEBD66Q28079509-AF3E308D-27F3-4C1B-BD55-B259E3F02247Q30235496-428338B1-8177-47B9-A804-2B0574B36B58Q33410582-8D4A41CF-D1FF-450E-9902-BE16A4CDE370Q34348230-262BBD14-7D17-48D5-9254-3CFB4775AAB7Q34685836-9D2C686C-3166-4EBB-AA52-9B5321B121C7Q34801940-24EF38F8-3A73-4FCB-9C78-85A157714719Q35037621-08962DF0-99F1-46A8-B5B6-783A5CEBE9BDQ35038942-0CD72E38-0B50-42B4-8146-EBD7B9BD1AB6Q35219180-BF26F3CF-EA38-42C1-99D0-C4DCFCFDBA8AQ35627684-EE35BFF7-7CEE-4086-9022-E3EAFF7AE531Q35672258-821FCC39-F366-4E54-AA2E-604067A6C352Q35680443-59E5F97F-55C0-4B6F-8ADE-C9385ADA633AQ35767479-7EF26687-ECFF-49C1-8C60-BC01A88EC33DQ36777599-B716F749-BE9A-47F9-B12D-5991E0881194Q37704224-DB5A8FBC-3070-49EB-AE06-76079DD2F4AAQ37785548-52CB3A62-2504-4E64-878E-714F916754F9Q37911513-9B6C9897-2AEC-4FCC-9754-C5BDAD8DA439Q37963475-753C9121-06F2-43E8-A192-02A29180199FQ37998072-093228B3-B904-4650-AB36-F0491A3D0109Q38045704-C12D76B9-59A9-4DED-9126-F7C52BA55CC9Q38126225-04ADC332-0784-4DB5-B939-9D5A8617E7D2Q38129837-9E61BAFF-8B12-49CF-960B-470C6490C87DQ38198120-45FB0804-78B6-4062-A50F-47B6E487C43FQ38269154-9CB9E9B1-0287-4DD0-8BE8-18540FD560ACQ38786977-C8E4EABD-ADEF-4973-A38B-8640BB64F079Q38797541-9EE92414-AE50-4023-A5D9-0365FB7744FFQ38797546-8A56EF55-E8AB-4CC1-A7FA-9E18B35E84EAQ38833951-827F6E74-1C2F-44E3-90F7-CA06CBBAE367Q38968737-25DB8E75-B6A1-48EA-A517-D1C0099FCFF7Q38971087-0EB0A02A-F5D2-4411-8569-4EF86E9B7294Q39010658-E5084236-180E-4031-8E17-B65F28E3E96BQ39202357-429BDBC2-BC99-415B-916F-A24171201B4CQ39287519-47269564-866F-47FE-82E4-47149B77AC8EQ39377722-F6646ECD-3C8C-46E1-9506-5193E3955F53Q39973043-023CF4B2-59B0-43B7-B172-F123FDF37EA7Q40113695-939BF1B7-7D64-4B6E-8032-9F39EE685377Q40115697-9390B8BF-BC45-44BE-93AD-38FF17F65FD1Q40116999-DB6B8DB0-40AA-46D5-B044-4083830DF04FQ40129026-FFCA4C33-97F2-42D9-990B-0AEAD49F2596
P2860
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines for preventing infe ...... ipients: a global perspective.
@en
Guidelines for preventing infe ...... ipients: a global perspective.
@nl
type
label
Guidelines for preventing infe ...... ipients: a global perspective.
@en
Guidelines for preventing infe ...... ipients: a global perspective.
@nl
prefLabel
Guidelines for preventing infe ...... ipients: a global perspective.
@en
Guidelines for preventing infe ...... ipients: a global perspective.
@nl
P2093
P356
P1476
Guidelines for preventing infe ...... ipients: a global perspective.
@en
P2093
American Society of Blood and Marrow Transplantation (ASBMT)
Association of Medical Microbiology and Infectious Diseases Canada (AMMI)
Canadian Blood and Marrow Transplant Group (CBMTG)
Center for International Blood and Marrow Transplant Research (CIBMTR)
Centers for Disease Control and Prevention (CDC)
European Blood and Marrow Transplant Group (EBMT)
Infectious Disease Society of America (IDSA)
National Marrow Donor Program (NMDP)
Society for Healthcare Epidemiology of America (SHEA)
P2888
P304
P356
10.1038/BMT.2009.254
P407
P577
2009-10-01T00:00:00Z
P5875
P6179
1001085030